Beruflich Dokumente
Kultur Dokumente
Ghosh
Asst. Professor Department of Medicine Medical College & Hospital, Kolkata
INTRODUCTION
Renal Physiology and Pharmacokinetics Drugs and normal kidney Drugs toxic to kidney Prescribing drugs in kidney diseases
RENAL PHYSIOLOGY
1. Extra Cellular Fluid Volume control 2. Electrolyte balance 3. Waste product excretion 4. Drug and hormone elimination/metabolism 5. Blood pressure regulation 6. Regulation of haematocrit 7. Regulation of calcium/phosphate balance (vitamin D3 metabolism)
PHARMACOKINETICS
1. 2. 3. 4.
Renal Excretion
Total amount of excretion of a drug depends on 1) Glomerular filtration: ~ plasma protein binding ~ renal blood flow 2) Tubular reabsorption ~ lipid solubility ~ ionization 3) Tubular secretion active transport of organic acids & bases If renal clearance of a drug >120ml/min (GFR), additional tubular secretion can be assumed to be occurring
Thiazide
Amiloride Loop
Drug related renal pathology can affect any / all kidney compartments 1) Tubulointerstitium is commonly involved, best known examples NSAID and antibiotics - drugs should be considered in all primary tubulointerstitial diseases 2) Glomeruli 3) Vasculature (only infrequently affected) - mimicks many primary renal diseases Mechanism: - immunologically mediated - toxic/ischemic damage dose is important for the later Dose dependent vs Idiosyncratic
TubuloTubulointerstitium
NSAID ACEACE-I Antibiotics Lithium Diazepam Bisphosphonate Cisplatin Methotrexate
Glomeruli
NSAID Lithium Bisphosphonate Propyithiouracil Cisplatin Mitomycin C Tamoxifen
Blood vs
Clopidogrel Quinine Phenytoin Sulfasalazine Propyithiouracil Mitomycin C Penicillamine
Patients with renal impairment Patients on Dialysis Patients with renal transplants
Clearance of drugs that are primarily excreted unchanged (aminoglycosides, digoxin) is reduced parallel to decrease in CrCL Loading dose of such a drug is not altered but maintenance doses should be reduced or dose interval prolonged proportionately Rough guide:
CrCL (ml/min) 5050-70 3030-50 1010-30 5-10 dose to be reduced by 1.5times 2 times 3 times 6 times
Dose rate of drugs, partly excreted unchanged in urine also needs reduction, but to lesser extent Plasma proteins, esp albumin, are often low or altered in structure in patients with renal diseases binding of acidic drugs is reduced but not that of basic drugs Permeability of BBB is increased in renal failure - Sedatives causes more CNS depression - Antihypertensive drugs produce more postural hypotension
Drugs worsen existing clinical condition in renal failure Antimicrobials requiring dose reduction in renal failure Even in mild failure Aminoglycosides Ethambutol Vancomycin Amphotreicin B Acyclovir Only in severe failure Cotrimoxazole Cefotaxime Ciprofloxacin, Norfloxacin Metronidazole
Diuretics : Thiazide diuretics tends to reduce GFR, ineffective in renal failure and can worsen uremia Potassium sparing diuretics are cotraindicated; can cause hyperkalemia
ASSESSMENT
Clinical features : Oliguria, anuria, hematuria Freqency Pedal swelling, facial puffiness, ascites Bone pain Vomitting Altered sensorium H/O drug intake CoCo-morbidities Pallor, BP, edema, volume status, flapping tremor Investigations
Routine tests : Hb%, serum albumin, urea, creatinine, electrolytes Urine R/E, M/E, C/S Urinary ACR Imaging : X-ray, USG, CT XClearance tests Nuclear scan Kidney biopsy
Two formulas are widely used to estimate GFR: 1) Cockcroft-Gault formula Cockcroft-